Article info

Download PDFPDF
Clinical therapeutics
Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease

Authors

Citation

Caldentey J, Lopéz-Sendón J, Trigo P, et al
Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease

Publication history

  • First published August 29, 2012.
Online issue publication 
August 29, 2012

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.